SOPHiA GENETICS (SOPH) EPS (Weighted Average and Diluted) (2022 - 2025)
SOPHiA GENETICS's (SOPH) quarterly EPS (Weighted Average and Diluted) came in at -$35406.8 in Q2 2025, down 4.76% year-on-year from -$37176.7 in Q2 2024, and down 4.76% quarter-over-quarter from -$33797.7 in Q2 2024.
SOPHiA GENETICS (SOPH) EPS (Weighted Average and Diluted) (2022 - 2025) Analysis & Trends
SOPHiA GENETICS has disclosed EPS (Weighted Average and Diluted) across 4 years of filings, most recently posting -$35406.8 for Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 1.57 |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 0.67 |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 0.82 |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 0.41 |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -0.10 |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 0.10 |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 0.22 |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 0.02 |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 0.25 |
| 10 | SOPHiA GENETICS | 26.19 Mn | -44.10 Mn | 14.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -35,406.78 |
| Jun 30, 2024 | -33,797.73 |
| Jun 30, 2023 | -33,203.13 |
| Jun 30, 2022 | -31,657.69 |